Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis M Dijkstra

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybinFrancis M Dijkstra, Gabriel E Jacobs, Adam F Cohen
Translational Psychiatry|March 1, 2023
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugsGuilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, et al.
British Journal of Clinical Pharmacology|January 11, 2022
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteersFrancis M Dijkstra, Rob G J A Zuiker, Pieter S Siebenga, et al.
Journal of Psychopharmacology (Oxford, England)|February 25, 2022
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorderFrancis M Dijkstra, Aurora Jae van de Loo, Smedra Abdulahad, et al.
British Journal of Clinical Pharmacology|September 19, 2023
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo-hallucinationsFrancis M Dijkstra, Rob G J A Zuiker, Jules A A C Heuberger, et al.
Translational Psychiatry|May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulationPatricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Lancet. Psychiatry|August 29, 2016
Question-based Drug Development for psilocybinFrancis M Dijkstra, Gabriel E Jacobs, Adam F Cohen
Translational Psychiatry|March 1, 2023
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugsGuilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, et al.
British Journal of Clinical Pharmacology|January 11, 2022
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteersFrancis M Dijkstra, Rob G J A Zuiker, Pieter S Siebenga, et al.
Journal of Psychopharmacology (Oxford, England)|February 25, 2022
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorderFrancis M Dijkstra, Aurora Jae van de Loo, Smedra Abdulahad, et al.
British Journal of Clinical Pharmacology|September 19, 2023
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo-hallucinationsFrancis M Dijkstra, Rob G J A Zuiker, Jules A A C Heuberger, et al.
Translational Psychiatry|May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulationPatricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Pageof 1